Skip to search formSkip to main contentSkip to account menu

5a-reductase inhibition

Known as: inhibition, 5a-reductase 
Treatment with a 5a-reductase inhibitor with the goal of suppressing the conversion of testosterone to dihydrotestosterone.
National Institutes of Health

Related topics

Related topics

1 relation
Hormone Therapy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Carcinogenicidad del D-004 en ratas Sprague Dawley. Reporte parcial a los 18 meses Carcinogenicity of D-004 in Sprague Dawley rats. A partial report at 18 months
Introduction: D-004, a lipid extract from royal palm (Roystonea regia) fruit made up of a reproducible mixture of fatty acids… 
Review
2004
Review
2004
‘Urology: Today's Advances, Tomorrow's Clinical Practice’, Cannes, November 2003
The year 2003 was an exciting one in urology with publication of two major studies, MTOPS and PCPT, the results of which are… 
2001
2001
New Progesterone Esters as 5α-Reductase Inhibitors
The pharmacological activity of four new progesterone derivatives: 4-bromo-17alpha-(p-fluorobenzoyloxy)-4-pregnene-3,20-dione (7… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)